Hematologic Cancers
Tiffany Richards provides an overview of the most common questions she hears from patients regarding daratumumab. Read More ›
Tiffany Richards expresses her positive outlook on daratumumab, citing that the treatment has helped extend life expentancies. Read More ›
Tiffany Richards explains the difficulties she has encountered in managing patients who have battled myeloma for an extended period of time and have experienced multiple relapses. Read More ›
Tiffany Richards identifies the many recources she leverages to stay current on new treatments. Read More ›
Leslie Lauersdorf hopes that multiple myeloma can eventually become a chronic disease, if not cured completely, so that patients with the disease can live life uninterrupted. Read More ›
Leslie Lauersdorf is excited by the prospect of new mutliple myeloma therapies, and notes that finding the best sequence for each patient is key. Read More ›
Leslie Lauersdorf notes that having patients assist in managing their own side effects is important to help them stay on treatment and improve their quality of life. Read More ›
Leslie Lauersdorf believes patient education is important in both newly diagnosed pateints with multiple myeloma or patients with relapsed/refractory disease to help them understand their disease and the different treatment options. Read More ›
Beth Faiman discusses the difficulty of keeping abreast of all the new multiple myeloma treatments and how she personally stays up to date on all of the information. Read More ›
Leslie Lauersdorf discusses the need to balance optimism and realism in caring for patients with relapsed/refractory multiple myeloma. Read More ›